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Improving the rate of PPSV-23 vaccination in children with Diabetes Mellitus
Henry Jeng, DO; Ryan McDonough, DO
Children’s Mercy Kansas City; Division of Pediatric Endocrinology and Diabetes
Background
The routine use of PCV-13 has resulted in a dramatic reduction in
the incidence of pneumococcal infections among young children.1
However, serious pneumococcal infections caused by additional
vaccine serotypes continue to occur in older children with high-risk
conditions.1 Thus, children with Diabetes should receive the PPSV23 vaccine beginning at 2 years of age and at least 8 weeks after
their last indicated dose of PCV-13.2
A review of Endocrinology division data from March 2016 to
November 2018 revealed that only 2.6% of children seen by
Endocrinology have received the PPSV-23 vaccine.3 The aim of this
project was to determine reasons for the low vaccination rate,
establish a protocol to set up tracking for the eligibility and
administration of PPSV-23 and to have a vaccination rate of at least
5% among the eligible patient population in a six-month period
from June to December 2020. This project is also part of a
multidisciplinary collaborative at CMH to improve PPSV-23
vaccination rates in eligible patients with chronic illnesses. 3
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Data and Analysis
From a data standpoint, tracking and monitoring of vaccination rate among
eligible patient population was carried out on a weekly basis. Eligibility is
defined as pediatric patient with history of either Type 1 or Type 2 Diabetes who
had completed childhood vaccination series of PCV-13, and thus were eligible to
receive PPSV-23 vaccine during their Diabetes clinic visit. Outcome measure is
the percentage of eligible patients vaccinated with PPSV-23 during Diabetes
clinic visit.

Summary
With PPSV-23 vaccine being indicated in all children with Diabetes beginning at 2
years of age, this project has been started in order to help improve the rate of
vaccination of this patient population at CMH. Root causes to the problem were
identified and countermeasures were put in place in order to rectify them.
Improvements in PPSV-23 vaccination rates were noted, although more work is
needed to sustain goal for another six-month period. Vaccination rates will be
monitored in conjunction with the CMH multidisciplinary collaborative to
improve vaccination rates in high-risk patients with chronic illnesses.
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